Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study

BACKGROUND: Immune checkpoint inhibitors (ICI)-based combination strategies have improved the survival outcomes in advanced non-small cell lung cancers; however, data regarding their efficacy remains limited for uncommon histological types, including large-cell carcinoma (LCC) and large-cell neuroen...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lianxi, Zhou, Fei, Xu, Tian, Zeng, Liang, Xia, Qing, Wang, Zhan, Deng, Li, Li, Yizhi, Qin, Haoyue, Yan, Huan, Huang, Zhe, Mi, Jinye, Xu, Qinqin, Yang, Nong, Zhou, Caicun, Zhang, Yongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186661/
https://www.ncbi.nlm.nih.gov/pubmed/37189075
http://dx.doi.org/10.1186/s12885-023-10952-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186661/
https://www.ncbi.nlm.nih.gov/pubmed/37189075
http://dx.doi.org/10.1186/s12885-023-10952-w

Ejemplares similares